BLFS biolifesolutions.com: Sof foyda bo'yicha sotuv rentabelligi

BioLife - BLFS emitenti grafik logotipi

Biomateriallarni ekspress yetkazib berishning murakkabliklariga qaramay, BioLife Solutions, Inc. (BLFS) qat'iy tozalik nazoratiga ega bo'lgan o'zining yuqori texnologik ob'ektlariga tayanadi. Choraklik savdo marjalari joriy samaradorlikni namoyish etmoqda va ko'rsatkich qiymati 46.40 ni tashkil etadi. Ushbu muvaffaqiyatga rahbarlik tomonidan ta'minlangan bo'lib, ular hujayralarni saqlash sohasidagi innovatsiyalar orqali kompaniyani biotexnologiya sektori uchun ajralmas hamkorga aylantirdi.

BioLife Solutions, Inc. (BLFS) - Kompaniya sotuv marjasi 04.07.2022dan 18.10.2026gacha

BioLife (BLFS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:BioLife Solutions, BLFS
BioLife Corp ishlab chiqargan mahsulot

BioLife Solutions, Inc. (BLFS) kompaniyasining gen terapiyasi kriyokonservatsiyasi segmentidagi samaradorligi qat'iy tibbiy sifat standartlarini monetizatsiya qilish qobiliyati bilan belgilanadi. Savdo marjasi trayektoriyasi har bir dollar daromadidagi sof foyda ulushini raqamlashtirib, investorlarga daromadlilikning vaqtincha pasayishini tizimli pasayishdan ajratish va biofarmatsevtika sikllari o'zgarishi davrida biznesning moliyaviy zaxirasini baholash imkonini beradi.

BioLife Solutions, Inc. kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX